3rd Apr 2025 7:00 am |
RNS-R |
FDA Annual Report |
31st Mar 2025 7:00 am |
RNS |
Total Voting Rights |
24th Mar 2025 7:00 am |
RNS |
First Patient Safety |
17th Mar 2025 7:00 am |
RNS |
Recruitment of Second Patient for Clinical Trials |
13th Mar 2025 3:10 pm |
RNS |
Conversion of convertible loan notes |
11th Mar 2025 7:00 am |
RNS |
Institutional investment |
24th Feb 2025 7:00 am |
RNS |
First-in-Human Treatment with HG-CT-1 |
19th Feb 2025 4:50 pm |
RNS |
Issue of convertible loan notes |
31st Jan 2025 9:35 am |
RNS |
Total Voting Rights |
8th Jan 2025 7:00 am |
RNS |
Placing to raise £340,000 |
2nd Jan 2025 7:00 am |
RNS |
Change of Company Secretary and Registered Office |
31st Dec 2024 7:00 am |
RNS |
Total Voting Rights |
30th Dec 2024 7:00 am |
RNS |
Opening of First Clinical Site |
19th Dec 2024 7:00 am |
RNS |
Ultrafast CAR-T Manufacturing |
10th Dec 2024 4:10 pm |
RNS |
Admission of New Ordinary Shares and New ISIN |
9th Dec 2024 1:30 pm |
RNS |
Result of Extraordinary General Meeting |
9th Dec 2024 7:00 am |
RNS |
Site Initiation Visit Completed |
6th Dec 2024 7:00 am |
RNS |
CBR Macrophage Delivery Update |
29th Nov 2024 7:00 am |
RNS |
Total Voting Rights |
22nd Nov 2024 12:49 pm |
RNS |
Notice of Extraordinary General Meeting |
22nd Nov 2024 7:00 am |
RNS |
IRB Approval for Phase I Clinical Trial |
11th Nov 2024 7:00 am |
RNS |
Institutional Investment |
30th Oct 2024 7:00 am |
RNS |
Schedule for Phase I Clinical Trial Opening |
2nd Oct 2024 11:19 am |
RNS |
Strategic Investment from Prevail Partners, LLC |
27th Sep 2024 7:00 am |
RNS |
Half-year Report |
9th Sep 2024 7:00 am |
RNS |
FLT3 Assay Ready for Phase I Trials at MD Anderson |
2nd Sep 2024 7:00 am |
RNS |
CDX Development Update |
28th Aug 2024 7:00 am |
RNS |
Presentation at CBD S&T Conference |
27th Jun 2024 4:39 pm |
RNS |
Result of Annual General Meeting |
17th Jun 2024 7:00 am |
RNS |
Operations Update |
3rd Jun 2024 7:00 am |
RNS |
Posting of Annual Report & Notice of AGM |
25th Apr 2024 7:00 am |
RNS |
Final Results |
28th Mar 2024 7:00 am |
RNS |
Total Voting Rights |
29th Feb 2024 7:00 am |
RNS |
Placing to Raise US$4.2 million |
16th Feb 2024 7:00 am |
RNS |
CBR Brain Delivery |
14th Feb 2024 7:00 am |
RNS |
CBR Intranasal Delivery |
9th Feb 2024 7:00 am |
RNS |
FDA Consents to Phase I Trials of HEMO-CAR-T |
2nd Feb 2024 7:00 am |
RNS |
Approval and Issuance of U.S. Conditioning Patent |
16th Jan 2024 7:00 am |
RNS |
Submission of Complete Response to Clinical Hold |
8th Jan 2024 7:00 am |
RNS |
HEMO-CAR-T Process Qualification Run Completed |